Advertisement

Topics

FDA surprises with rejection of Pfizer's Epogen biosimilar

06:00 EDT 23 Jun 2017 | BioPharmaDive

Manufacturing issues at a Kansas production site tripped up approval of the copycat biologic. 

Original Article: FDA surprises with rejection of Pfizer's Epogen biosimilar

NEXT ARTICLE

More From BioPortfolio on "FDA surprises with rejection of Pfizer's Epogen biosimilar"

Advertisement
Quick Search
Advertisement
Advertisement